View in EDS PDF Full Text

Application of recombinant hemagglutinin proteins as alternative antigen standards for pandemic influenza vaccines.

Saved in:
Bibliographic Details
Title: Application of recombinant hemagglutinin proteins as alternative antigen standards for pandemic influenza vaccines.
Authors: Choi Y; Vaccines Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea.; Department of Biochemistry, College of Natural Sciences, Chungbuk National University, Cheongju-si, Chungcheongbuk-do, 28644, Republic of Korea., Kwon SY; Vaccines Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea., Oh HJ; Vaccines Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea. audrihojung@hanmail.net., Shim S; Vaccines Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea., Chang S; Vaccines Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea., Chung HJ; Vaccines Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea., Kim DK; Biologics Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea., Park Y; Vaccines Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea., Lee Y; Department of Biochemistry, College of Natural Sciences, Chungbuk National University, Cheongju-si, Chungcheongbuk-do, 28644, Republic of Korea.
Source: Biotechnology letters [Biotechnol Lett] 2017 Sep; Vol. 39 (9), pp. 1375-1380. Date of Electronic Publication: 2017 Jun 13.
Publication Type: Evaluation Study; Journal Article
Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 8008051 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-6776 (Electronic) Linking ISSN: 01415492 NLM ISO Abbreviation: Biotechnol Lett Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28612264
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Application of recombinant hemagglutinin proteins as alternative antigen standards for pandemic influenza vaccines.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Choi+Y%22">Choi Y</searchLink>; Vaccines Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea.; Department of Biochemistry, College of Natural Sciences, Chungbuk National University, Cheongju-si, Chungcheongbuk-do, 28644, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kwon+SY%22">Kwon SY</searchLink>; Vaccines Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Oh+HJ%22">Oh HJ</searchLink>; Vaccines Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea. audrihojung@hanmail.net.<br /><searchLink fieldCode="AU" term="%22Shim+S%22">Shim S</searchLink>; Vaccines Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Chang+S%22">Chang S</searchLink>; Vaccines Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Chung+HJ%22">Chung HJ</searchLink>; Vaccines Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+DK%22">Kim DK</searchLink>; Biologics Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+Y%22">Park Y</searchLink>; Vaccines Division, National Institute of Food and Drug Safety Evaluation, 187 Osongsaengmyeoung 2-ro, Osong-eup, Heungdoek-gu, Cheongju-si, Chungcheongbuk-do, 28159, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+Y%22">Lee Y</searchLink>; Department of Biochemistry, College of Natural Sciences, Chungbuk National University, Cheongju-si, Chungcheongbuk-do, 28644, Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228008051%22">Biotechnology letters</searchLink> [Biotechnol Lett] 2017 Sep; Vol. 39 (9), pp. 1375-1380. <i>Date of Electronic Publication: </i>2017 Jun 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Evaluation Study; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic+Publishers%22">Kluwer Academic Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8008051 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-6776 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201415492%22">01415492 </searchLink><i>NLM ISO Abbreviation: </i>Biotechnol Lett <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28612264
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10529-017-2372-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1375
    Titles:
      – TitleFull: Application of recombinant hemagglutinin proteins as alternative antigen standards for pandemic influenza vaccines.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Choi Y
      – PersonEntity:
          Name:
            NameFull: Kwon SY
      – PersonEntity:
          Name:
            NameFull: Oh HJ
      – PersonEntity:
          Name:
            NameFull: Shim S
      – PersonEntity:
          Name:
            NameFull: Chang S
      – PersonEntity:
          Name:
            NameFull: Chung HJ
      – PersonEntity:
          Name:
            NameFull: Kim DK
      – PersonEntity:
          Name:
            NameFull: Park Y
      – PersonEntity:
          Name:
            NameFull: Lee Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2017 Sep
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1573-6776
          Numbering:
            – Type: volume
              Value: 39
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Biotechnology letters
              Type: main
ResultId 1